Proveca is a global pharmaceutical company which specialises in the development and licensing of medicines to address unmet medical needs in children.
Explore our latest news below to discover more.
If you are an investor please visit the designated investor page.
Published November 29 2022
Proveca Ltd has partnered with Aston University. The new partnership brings together the academic excellence of Aston University with the paediatric pharmaceutical expertise of Proveca which will ultimately drive innovation in paediatric medicines to improve child health.
Published January 5 2022
Alder Hey children’s hospital and Proveca Ltd are joining forces with the aim of improving medicines for children and young people. The new collaborative partnership plans to provide the best pharmaceutical treatments for children by identifying existing gaps and developing new products specifically for – and with – children and young people.